Institutional Repository of Vilnius University
SARS-CoV-2 pagrindinės proteazės slopiklių paieška ir jų sąveikos tyrimai /
Abstract
dc:descriptionThe single-stranded RNA genome of SARS-CoV-2 encodes 29 proteins, which include the main protease (Mpro). It is a highly conservative protease that employs a cysteine side chain in the active site, which participates in the cleavage of the viral polypeptides during viral replication. The enzyme has a unique substrate preference for glutamine at the P1 site (Leu-Gln↓(Ser, Ala, Gly)). Released proteins are essential for both viral replication and the assembly of viral particles in the host cells. Therefore, SARS-CoV-2 Mpro has been intensively explored as a potential target for antiviral drug development. The search for chemical compounds that would act as antiviral drugs against SARS-CoV-2 has been of great importance. In this study, a broad range of chemical compounds was investigated and their binding affinity to the SARS-CoV-2 main protease was evaluated by in vitro fluorescent thermal shift and FRET-based enzymatic assays. The results revealed that peptidomimetics imitating the structure of the SARS-CoV-2 main protease substrate are the most potent inhibitors of the protease. The study suggests that disulfides and compounds bearing thiazole ring could be considered as potential Mpro inhibitors. Naturally derived flavonoids that are secondary metabolites synthesized by plants also demonstrated high affinity towards Mpro. Epigallocatechin gallate (Kd = 440 nM), found in dried green tea leaves, was the most potent flavonoid inhibiting the protease. The binding affinity of epigallocatechin gallate depend on incubation time. This compound is known for inhibiting signaling pathways responsible for the excessive expression of pro-inflammatory cytokines and chemokines, therefore could be widely applied as the potential inhibitor of SARS-CoV-2 Mpro.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Čerepenkaitė, Kamilė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192838926&prefLang=en_US